ZEBRA TECHNOLOGIES CORP-CL A (ZBRA)

US9892071054 - Common Stock

385.63  -0.59 (-0.15%)

Fundamental Rating

5

Overall ZBRA gets a fundamental rating of 5 out of 10. We evaluated ZBRA against 126 industry peers in the Electronic Equipment, Instruments & Components industry. ZBRA scores excellent on profitability, but there are some minor concerns on its financial health. ZBRA has a decent growth rate and is not valued too expensively.



7

1. Profitability

1.1 Basic Checks

ZBRA had positive earnings in the past year.
In the past year ZBRA had a positive cash flow from operations.
Each year in the past 5 years ZBRA has been profitable.
ZBRA had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

ZBRA has a Return On Assets of 4.97%. This is in the better half of the industry: ZBRA outperforms 72.73% of its industry peers.
ZBRA has a better Return On Equity (11.17%) than 76.86% of its industry peers.
ZBRA has a better Return On Invested Capital (8.92%) than 77.69% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ZBRA is significantly above the industry average of 9.20%.
The 3 year average ROIC (14.81%) for ZBRA is well above the current ROIC(8.92%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 4.97%
ROE 11.17%
ROIC 8.92%
ROA(3y)7.89%
ROA(5y)8.92%
ROE(3y)18.25%
ROE(5y)21.57%
ROIC(3y)14.81%
ROIC(5y)16.07%

1.3 Margins

ZBRA's Profit Margin of 8.20% is fine compared to the rest of the industry. ZBRA outperforms 77.69% of its industry peers.
In the last couple of years the Profit Margin of ZBRA has declined.
With an excellent Operating Margin value of 13.51%, ZBRA belongs to the best of the industry, outperforming 88.43% of the companies in the same industry.
In the last couple of years the Operating Margin of ZBRA has declined.
ZBRA has a Gross Margin of 47.53%. This is amongst the best in the industry. ZBRA outperforms 82.64% of its industry peers.
ZBRA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 13.51%
PM (TTM) 8.2%
GM 47.53%
OM growth 3Y-6.07%
OM growth 5Y-3.07%
PM growth 3Y-17.09%
PM growth 5Y-8.34%
GM growth 3Y0.94%
GM growth 5Y-0.28%

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ZBRA is creating some value.
ZBRA has less shares outstanding than it did 1 year ago.
The number of shares outstanding for ZBRA has been reduced compared to 5 years ago.
The debt/assets ratio for ZBRA is higher compared to a year ago.

2.2 Solvency

An Altman-Z score of 4.62 indicates that ZBRA is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.62, ZBRA is in the better half of the industry, outperforming 70.25% of the companies in the same industry.
The Debt to FCF ratio of ZBRA is 2.82, which is a good value as it means it would take ZBRA, 2.82 years of fcf income to pay off all of its debts.
ZBRA has a better Debt to FCF ratio (2.82) than 70.25% of its industry peers.
ZBRA has a Debt/Equity ratio of 0.61. This is a neutral value indicating ZBRA is somewhat dependend on debt financing.
ZBRA has a worse Debt to Equity ratio (0.61) than 80.17% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 2.82
Altman-Z 4.62
ROIC/WACC0.87
WACC10.26%

2.3 Liquidity

ZBRA has a Current Ratio of 1.37. This is a normal value and indicates that ZBRA is financially healthy and should not expect problems in meeting its short term obligations.
ZBRA has a worse Current ratio (1.37) than 85.95% of its industry peers.
ZBRA has a Quick Ratio of 1.37. This is a bad value and indicates that ZBRA is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.96, ZBRA is not doing good in the industry: 81.82% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.37
Quick Ratio 0.96

4

3. Growth

3.1 Past

ZBRA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -12.68%.
Measured over the past years, ZBRA shows a decrease in Earnings Per Share. The EPS has been decreasing by -2.30% on average per year.
The Revenue has decreased by -8.31% in the past year.
ZBRA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.68% yearly.
EPS 1Y (TTM)-12.68%
EPS 3Y-8.51%
EPS 5Y-2.3%
EPS Q2Q%301.15%
Revenue 1Y (TTM)-8.31%
Revenue growth 3Y1.01%
Revenue growth 5Y1.68%
Sales Q2Q%31.28%

3.2 Future

The Earnings Per Share is expected to grow by 19.34% on average over the next years. This is quite good.
The Revenue is expected to grow by 6.94% on average over the next years.
EPS Next Y38.98%
EPS Next 2Y28.68%
EPS Next 3Y22.99%
EPS Next 5Y19.34%
Revenue Next Year8.53%
Revenue Next 2Y8.27%
Revenue Next 3Y7.58%
Revenue Next 5Y6.94%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 34.37, which means the current valuation is very expensive for ZBRA.
ZBRA's Price/Earnings is on the same level as the industry average.
ZBRA is valuated rather expensively when we compare the Price/Earnings ratio to 27.17, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 23.74, the valuation of ZBRA can be described as rather expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ZBRA is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.59, ZBRA is valued at the same level.
Industry RankSector Rank
PE 34.37
Fwd PE 23.74

4.2 Price Multiples

ZBRA's Enterprise Value to EBITDA is on the same level as the industry average.
Based on the Price/Free Cash Flow ratio, ZBRA is valued a bit cheaper than the industry average as 68.59% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 25.9
EV/EBITDA 26.67

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of ZBRA may justify a higher PE ratio.
A more expensive valuation may be justified as ZBRA's earnings are expected to grow with 22.99% in the coming years.
PEG (NY)0.88
PEG (5Y)N/A
EPS Next 2Y28.68%
EPS Next 3Y22.99%

0

5. Dividend

5.1 Amount

No dividends for ZBRA!.
Industry RankSector Rank
Dividend Yield N/A

ZEBRA TECHNOLOGIES CORP-CL A

NASDAQ:ZBRA (1/2/2025, 11:17:06 AM)

385.63

-0.59 (-0.15%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)10-29 2024-10-29/bmo
Earnings (Next)02-13 2025-02-13/amc
Inst Owners92.98%
Inst Owner Change-2.07%
Ins Owners0.71%
Ins Owner Change-0.52%
Market Cap19.89B
Analysts75.83
Price Target417.12 (8.17%)
Short Float %1.06%
Short Ratio1.44
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.45%
Min EPS beat(2)5.75%
Max EPS beat(2)11.15%
EPS beat(4)4
Avg EPS beat(4)7.95%
Min EPS beat(4)1.12%
Max EPS beat(4)13.76%
EPS beat(8)6
Avg EPS beat(8)4.38%
EPS beat(12)9
Avg EPS beat(12)2.86%
EPS beat(16)13
Avg EPS beat(16)4.79%
Revenue beat(2)2
Avg Revenue beat(2)1.06%
Min Revenue beat(2)1%
Max Revenue beat(2)1.13%
Revenue beat(4)3
Avg Revenue beat(4)0.39%
Min Revenue beat(4)-0.98%
Max Revenue beat(4)1.13%
Revenue beat(8)5
Avg Revenue beat(8)-0.8%
Revenue beat(12)6
Avg Revenue beat(12)-1.22%
Revenue beat(16)9
Avg Revenue beat(16)-0.77%
PT rev (1m)0%
PT rev (3m)10.78%
EPS NQ rev (1m)0%
EPS NQ rev (3m)18.4%
EPS NY rev (1m)0%
EPS NY rev (3m)5.24%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)7.09%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.16%
Valuation
Industry RankSector Rank
PE 34.37
Fwd PE 23.74
P/S 4.27
P/FCF 25.9
P/OCF 23.46
P/B 5.81
P/tB N/A
EV/EBITDA 26.67
EPS(TTM)11.22
EY2.91%
EPS(NY)16.24
Fwd EY4.21%
FCF(TTM)14.89
FCFY3.86%
OCF(TTM)16.44
OCFY4.26%
SpS90.27
BVpS66.32
TBVpS-17.86
PEG (NY)0.88
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.97%
ROE 11.17%
ROCE 10.26%
ROIC 8.92%
ROICexc 10.02%
ROICexgc 49.22%
OM 13.51%
PM (TTM) 8.2%
GM 47.53%
FCFM 16.49%
ROA(3y)7.89%
ROA(5y)8.92%
ROE(3y)18.25%
ROE(5y)21.57%
ROIC(3y)14.81%
ROIC(5y)16.07%
ROICexc(3y)15.53%
ROICexc(5y)16.7%
ROICexgc(3y)146.76%
ROICexgc(5y)N/A
ROCE(3y)17.05%
ROCE(5y)18.5%
ROICexcg growth 3YN/A
ROICexcg growth 5Y-26.39%
ROICexc growth 3Y-19.87%
ROICexc growth 5Y-12.95%
OM growth 3Y-6.07%
OM growth 5Y-3.07%
PM growth 3Y-17.09%
PM growth 5Y-8.34%
GM growth 3Y0.94%
GM growth 5Y-0.28%
F-Score7
Asset Turnover0.61
Health
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 2.82
Debt/EBITDA 2.59
Cap/Depr 45.98%
Cap/Sales 1.72%
Interest Coverage 250
Cash Conversion 105.6%
Profit Quality 201.05%
Current Ratio 1.37
Quick Ratio 0.96
Altman-Z 4.62
F-Score7
WACC10.26%
ROIC/WACC0.87
Cap/Depr(3y)39.25%
Cap/Depr(5y)39.7%
Cap/Sales(3y)1.41%
Cap/Sales(5y)1.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-12.68%
EPS 3Y-8.51%
EPS 5Y-2.3%
EPS Q2Q%301.15%
EPS Next Y38.98%
EPS Next 2Y28.68%
EPS Next 3Y22.99%
EPS Next 5Y19.34%
Revenue 1Y (TTM)-8.31%
Revenue growth 3Y1.01%
Revenue growth 5Y1.68%
Sales Q2Q%31.28%
Revenue Next Year8.53%
Revenue Next 2Y8.27%
Revenue Next 3Y7.58%
Revenue Next 5Y6.94%
EBIT growth 1Y-17.78%
EBIT growth 3Y-5.12%
EBIT growth 5Y-1.44%
EBIT Next Year54.76%
EBIT Next 3Y24.17%
EBIT Next 5Y18.23%
FCF growth 1Y101.05%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y86.78%
OCF growth 3YN/A
OCF growth 5YN/A